Fab'-bearing siRNA TNFα-loaded nanoparticles targeted to colonic macrophages offer an effective therapy for experimental colitis.
about
Nanomedicine and drug delivery strategies for treatment of inflammatory bowel diseaseRNA interference-based nanosystems for inflammatory bowel disease therapyRecent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel diseaseSynthetic Nanoparticles for Vaccines and ImmunotherapyEdible Ginger-derived Nano-lipids Loaded with Doxorubicin as a Novel Drug-delivery Approach for Colon Cancer TherapyAntibody fragments as nanoparticle targeting ligands: a step in the right directionPolymeric nanoparticle drug delivery technologies for oral delivery applications.Plant derived edible nanoparticles as a new therapeutic approach against diseases.Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.Targeted delivery systems for biological therapies of inflammatory diseases.Nanomedicines in gastroenterology and hepatology.Personalizing Biomaterials for Precision Nanomedicine Considering the Local Tissue Microenvironment.Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases.Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.Engineered Hydrogels for Local and Sustained Delivery of RNA-Interference Therapies.Polymer-based drug delivery: the quest for local targeting of inflamed intestinal mucosa.Liposomal Delivery of Diacylglycerol Lipase-Beta Inhibitors to Macrophages Dramatically Enhances Selectivity and Efficacy in Vivo.Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis.Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.Polysaccharides for the Delivery of Antitumor Drugs.Nanoparticle Vaccines Against Infectious Diseases
P2860
Q26777400-2DC7F447-0FE3-4672-AA74-951211CFD33CQ28071518-98557123-4D2D-4703-8B0E-6BAAEE297E7EQ28073219-E06C1AAA-EC93-4E08-AC8B-6826DBCFA18EQ28085375-BEB62581-E1D5-48A1-8CFA-8693C0CC4A28Q28394225-22CFF004-999A-44C3-B72F-59064AE9B147Q36357291-D883CED9-ECD4-4339-BC2E-4FEB5EA0F814Q36808308-2C172A70-8327-45BC-B494-EA882087BBFCQ37012929-C8D3741F-50C4-4FF7-B24B-651C369F5BC9Q37469872-B7F4ABE9-AB29-4181-8987-7017B29511A3Q38264691-7110CE10-C3DF-4DDE-938D-1EDC2964D254Q38370747-D8379021-C4D1-42FB-AE00-AD0E927BEDB6Q38473948-835C5944-DF2D-4BC2-998A-3B452CFF2870Q38659150-347CEE0D-DDE1-49B2-81D5-E23500FD78CDQ38862706-2AC36ED0-228F-4203-A125-34EA0B6410A0Q39038930-B8D5FD9F-A80F-4730-8A8B-D0E5C96EC6D1Q39170844-9B64478B-58BE-44AD-8C81-31B88ECAB1F3Q45067287-C993CA8A-CDA6-4219-BBB7-FB219183D94DQ47840447-6C68ABAF-A9F9-4607-A1DB-6CF6A9BEB0D7Q47980720-96D5ECEE-C177-4FC3-8E40-242A0CA8D53DQ50347968-3D435E24-2B32-4983-AC96-CA13DBABF81FQ58583890-2C21668C-1566-400A-88BE-AF4003A7C4F5
P2860
Fab'-bearing siRNA TNFα-loaded nanoparticles targeted to colonic macrophages offer an effective therapy for experimental colitis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Fab'-bearing siRNA TNFα-loaded ...... rapy for experimental colitis.
@en
type
label
Fab'-bearing siRNA TNFα-loaded ...... rapy for experimental colitis.
@en
prefLabel
Fab'-bearing siRNA TNFα-loaded ...... rapy for experimental colitis.
@en
P2093
P2860
P50
P1476
Fab'-bearing siRNA TNFα-loaded ...... erapy for experimental colitis
@en
P2093
Brandon S B Canup
Didier Merlin
Hamed Laroui
P2860
P356
10.1016/J.JCONREL.2014.04.046
P407
P577
2014-05-05T00:00:00Z